Update On Oral Thin Film Drug Delivery Programs
Sep 22, 2020
Vancouver, Canada (September 22, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next-generation bioscience company, is pleased to...
Update On COVID-19 Rapid Test Commercialization
Sep 8, 2020
Vancouver, Canada (September 8, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next generation bioscience company, is pleased...
XPhyto Provides Update On Parkinsons’ Transdermal Patch
Aug 25, 2020
Vancouver, Canada (August 25, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next generation bioscience company, is pleased...
XPhyto Announces OTCQB Venture Market Listing
Aug 14, 2020
Vancouver, Canada (August 14, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next generation bioscience company, is pleased...
XPhyto Provides Update On COVID-19 Rapid Test
Aug 9, 2020
Vancouver, Canada (August 10, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next generation bioscience company, is pleased...
COVID-19 Rapid Screening Test Prototype Validation
Jul 7, 2020
Vancouver, Canada (July 6, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its exclusive...
Infectious Disease Oral Biosensor Function Confirmed
Jun 29, 2020
Vancouver, Canada (June 29, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its diagnostic...
Infectious Disease Oral Screening Test Advancement
Jun 15, 2020
Vancouver, Canada (June 15, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its wholly...
Diagnostic Partner 3a Receives BMBF Grant for Infectious Disease Screening Tests
Jun 10, 2020
Vancouver, Canada (June 10, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its diagnostic...
Parkinson’s Generic Transdermal Drug Delivery System
Jun 8, 2020
Vancouver, Canada (June 8, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its wholly...
Exclusive Agreement with Oettinger Brewery for Cannabis-Infused Beverages signed
May 12, 2020
Vancouver, Canada (May 12, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that it has...
Infectious Disease Oral Dissolvable Biosensor Development
Apr 22, 2020
Vancouver, Canada (April 22, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that further to...
